Biotech

Angle PLC: Holding(s) in Company

GUILDFORD, SURREY: ...

Flamel Technologies Reaches Agreement With FDA on Protocol for Phase III Pivotal Trial of FT218

LYON, FRANCE: ...

Prima Abstracts Accepted for Poster Presentation at ESMO Symposium on Immuno-Oncology

SYDNEY, AUSTRALIA: ...

Golden Leaf Holdings Ltd Common Shares Approved for Inclusion on the OTCQB Market

TORONTO, ONTARIO: ...

Bioz Announces Distinguished Scientific Advisory Board With Three Nobel Laureates

PALO ALTO, CA: Software Startup Taps the Minds of Accomplished Scientists to Advise on Improving Life Science Experimentation ...

Theravance Biopharma Announces First Subject Dosed in Phase 1b Clinical Trial of TD-1473 in Patients With Moderate to Severe Ulcerative Colitis

DUBLIN, IRELAND: Intestinally Restricted Pan-Janus Kinase (JAK) Inhibitor Designed to Act Directly at Site of Inflammation in the Intestinal Wall With Minimal Systemic Exposure ...

Boston Therapeutics Completes Private Offering, Appoints New CEO

LAWRENCE, MA: Closes $1.6 Million Convertible Debt Offering ...

Hemostemix Granted Two Additional Patents in the US and in Canada

TORONTO, ONTARIO: ...

Sernova Announces Appointment of New CFO

LONDON, ONTARIO: Pharma Veteran Scott Langille Brings Over 25 Years of Experience in Both Canada and the United States to Sernova ...

iBio Proprietary Technology Advances Neonatal Respiratory Distress Syndrome Drug Development for South African Biotech Company AzarGen Biotechnologies (Pty) Ltd

NEW YORK, NY: ...